cis-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride

Catalog No. :
ACMGIP088
CAS No. :
1909288-04-5
Molecular Formula :
C6H12ClNO3
Molecular Weight :
181.62

IUPAC Name:(1s,3s)-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride

cis-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$760.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride
IUPAC Name(1s,3s)-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride
MDL No.MFCD29055149
Molecular FormulaC6H12ClNO3
Molecular Weight181.62
SMILESO=C([C@@]1(N)C[C@](C)(O)C1)O.[H]Cl
InChI KeyDIHQZGNZMKSYOQ-KNCHESJLSA-N
Synonymcis-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride;(1r,3s)-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride, trans;rac-(1R,3S)-1-Amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride;(1s,3s)-1-amino-3-hydroxy-3-methylcyclobutane-1-carboxylic acid hydrochloride
CAS No.1909288-04-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMGIP088 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGIP088 route product structure diagram
    ACMGIP0881909288-04-5
Inquiry

2. ACMGIP088 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGIP088 route product structure diagram
    ACMGIP0881909288-04-5
Inquiry

Comments (0)